Company Filing History:
Years Active: 2018
Title: Alessandro Gagnoni: Innovator in Pharmaceutical Chemistry
Introduction
Alessandro Gagnoni is a notable inventor based in Luino Varese, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel drug formulations. His work focuses on improving the efficacy and safety of treatments for various diseases.
Latest Patents
Gagnoni holds a patent for "Crystal forms of immunomodulatory drug pomalidomide and co-crystal with gentisic acid." This invention relates to novel solid crystal forms of Pomalidomide, specifically Form B, Form M, and the Pomalidomide:Gentisic acid co-crystal. These solid forms are advantageous in pharmaceutical compositions for treating and preventing multiple myeloma, inflammatory diseases, autoimmune diseases, myelodysplastic syndrome, myeloproliferative disorders, anemia, scleroderma, amyloidosis, and other diseases associated with unwanted angiogenesis. He has 1 patent to his name.
Career Highlights
Gagnoni is associated with F.I.S. Fabbrica Italiana Sintetici S.p.a., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing drug formulations that can significantly impact patient care.
Collaborations
He collaborates with esteemed colleagues such as Antonio Germani and Nicolas Tesson, contributing to a dynamic research environment that fosters innovation and development in pharmaceutical sciences.
Conclusion
Alessandro Gagnoni's contributions to pharmaceutical chemistry, particularly through his patent on Pomalidomide formulations, highlight his role as a key innovator in the field. His work continues to pave the way for advancements in treatments for serious medical conditions.